Edit
Sagent Pharmaceuticals
http://www.sagentpharma.com/?portfolioCats=34,23,29,35,22,24,30,25,28,31#new_tabSagent Holding Co. is a generic specialty injectable (“SIP”) pharmaceutical company targeting the US hospital and clinical markets, with manufacturing facilities in China and sales, marketing and distribution in the US. Founded in late 2006, Sagent leverages global R&D resources, US distribution and Chinese manufacturing to realize increased value along the supply chain and higher return on equity.
CRCI successfully exited this investment in November 2011, at 2.0x ROI and 25.5% IRR.
Total raised: $30M
Investors 2
| Date | Name | Website |
| - | China Rena... | crcicapita... |
| - | Vivo Capit... | vivocapita... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 21.05.2009 | Series A | $30M | - | medcitynew... |
Mentions in press and media 5
| Date | Title | Description | Category | Author | Source |
| 12.02.2021 | Sagent Pha... | SCHAUMBURG, Ill., Feb. 12, 2... | - | - | prnewswire... |
| 08.04.2010 | Sagent Pha... | Sagent Pharmaceuticals, a Scha... | China mid... | - | finsmes.co... |
| 21.05.2009 | Sagent Pha... | Promoted Clinical Care Capaci... | - | - | medcitynew... |
| 28.09.2007 | Life scien... | Featured companies: Imalux, Sa... | - | - | venturebea... |
| - | Sagent Pha... | SCHAUMBURG, Illinois — Injecta... | - | - | medcitynew... |